Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1992 1
1993 1
1994 2
1995 6
1996 14
1997 32
1998 74
1999 94
2000 134
2001 189
2002 240
2003 349
2004 389
2005 521
2006 542
2007 526
2008 594
2009 539
2010 591
2011 659
2012 658
2013 625
2014 674
2015 634
2016 611
2017 626
2018 630
2019 636
2020 593
2021 622
2022 547
2023 548
2024 581
2025 638
2026 24

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12,628 results

Results by year

Filters applied: . Clear all
Page 1
Clinical pharmacokinetics of atorvastatin.
Lennernäs H. Lennernäs H. Clin Pharmacokinet. 2003;42(13):1141-60. doi: 10.2165/00003088-200342130-00005. Clin Pharmacokinet. 2003. PMID: 14531725 Review.
The clinical dosage range for atorvastatin is 10-80 mg/day, and it is given in the acid form. Atorvastatin acid is highly soluble and permeable, and the drug is completely absorbed after oral administration. ...The total plasma clearance of atorvastatin acid …
The clinical dosage range for atorvastatin is 10-80 mg/day, and it is given in the acid form. Atorvastatin acid is highly solu …
Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial.
Ballantyne CM, Houri J, Notarbartolo A, Melani L, Lipka LJ, Suresh R, Sun S, LeBeaut AP, Sager PT, Veltri EP; Ezetimibe Study Group. Ballantyne CM, et al. Circulation. 2003 May 20;107(19):2409-15. doi: 10.1161/01.CIR.0000068312.21969.C8. Epub 2003 Apr 28. Circulation. 2003. PMID: 12719279 Clinical Trial.
The primary efficacy end point was percentage reduction in LDL-C for pooled ezetimibe plus atorvastatin versus pooled atorvastatin treatment groups. Ezetimibe plus atorvastatin significantly improved LDL-C, HDL cholesterol (HDL-C), triglycerides, total choles …
The primary efficacy end point was percentage reduction in LDL-C for pooled ezetimibe plus atorvastatin versus pooled atorvastatin …
Atorvastatin-Associated Gynecomastia.
Famularo G, Sarrecchia C. Famularo G, et al. Ann Pharmacother. 2021 Oct;55(10):1300-1301. doi: 10.1177/1060028021988994. Epub 2021 Jan 20. Ann Pharmacother. 2021. PMID: 33472378 No abstract available.
[Atorvastatin (Lipitor)].
Carpentier Y, Ducobu J, Sternon J. Carpentier Y, et al. Rev Med Brux. 1999 Oct;20(5):427-33. Rev Med Brux. 1999. PMID: 10582478 Review. French.
The prolonged half-life (20-30 H) of atorvastatin and its active metabolites, induces a prolonged inhibition of HMG Co-A reductase and a reduction of hepatitic apo B production. The biological efficacy of atorvastatin is high: 41 to 61% lowering of LDL depending of …
The prolonged half-life (20-30 H) of atorvastatin and its active metabolites, induces a prolonged inhibition of HMG Co-A reductase an …
Cholesterol-absorbed in thought.
Tietge UJ. Tietge UJ. Curr Opin Lipidol. 2016 Apr;27(2):202-3. doi: 10.1097/MOL.0000000000000283. Curr Opin Lipidol. 2016. PMID: 26959709 No abstract available.
Lipitor (atorvastatin calcium) tablets.
Claussen DW. Claussen DW. Gastroenterol Nurs. 1998 Sep-Oct;21(5):219-20. doi: 10.1097/00001610-199809000-00008. Gastroenterol Nurs. 1998. PMID: 9830966 Review. No abstract available.
Atorvastatin rescues vascular endothelial injury in hypertension by WWP2-mediated ubiquitination and degradation of ATP5A.
Yin Z, You S, Zhang S, Zhang L, Wu B, Huang X, Lu S, Cao L, Zhang Y, Li D, Zhang X, Liu J, Sun Y, Zhang N. Yin Z, et al. Biomed Pharmacother. 2023 Oct;166:115228. doi: 10.1016/j.biopha.2023.115228. Epub 2023 Aug 7. Biomed Pharmacother. 2023. PMID: 37557013 Free article.
As a widely used lipid-lowering drug in clinical practice, atorvastatin is widely recognized for its role in protecting vascular endothelium in the cardiovascular system. However, a clear mechanistic understanding of its action is lacking. Here, we found that atorvastat …
As a widely used lipid-lowering drug in clinical practice, atorvastatin is widely recognized for its role in protecting vascular endo …
Impact of atorvastatin on erectile dysfunction: A meta-analysis and systematic review.
Su H, Lu Y, Ma C, Li H, Su X. Su H, et al. Andrologia. 2022 Jul;54(6):e14408. doi: 10.1111/and.14408. Epub 2022 Feb 27. Andrologia. 2022. PMID: 35224753
Atorvastatin may be an effective treatment for erectile dysfunction (ED). The purpose of this meta-analysis was to determine whether atorvastatin therapy is effective in the treatment of ED. ...A meta-analysis of randomized controlled trials (RCTs) was done to inves …
Atorvastatin may be an effective treatment for erectile dysfunction (ED). The purpose of this meta-analysis was to determine whether …
Atorvastatin improved ulcerative colitis in association with gut microbiota-derived tryptophan metabolism.
Gou Y, Cai S, Chen Y, Hou X, Zhang J, Bi C, Gu P, Yang M, Zhang H, Zhong W, Yuan H. Gou Y, et al. Life Sci. 2024 Aug 15;351:122790. doi: 10.1016/j.lfs.2024.122790. Epub 2024 Jun 7. Life Sci. 2024. PMID: 38852795 Free article.
AIMS: Atorvastatin is a commonly used cholesterol-lowering drug that possesses non-canonical anti-inflammatory properties. ...Atorvastatin treatment reduced the level of pro-inflammatory cytokines interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF-alpha). ...
AIMS: Atorvastatin is a commonly used cholesterol-lowering drug that possesses non-canonical anti-inflammatory properties. ...Ator …
Immunomodulatory effects of atorvastatin on MRL/lpr mice.
Sun J, Xu W, Wu Z, Cao C, Tan Y, Zhu M, Wu H, Yu J. Sun J, et al. Adv Rheumatol. 2022 Dec 5;62(1):47. doi: 10.1186/s42358-022-00282-z. Adv Rheumatol. 2022. PMID: 36471414 Free PMC article.
In vivo, the effects of atorvastatin on the survival rate, renal function and spleen index in MRL/lpr mice were examined. ...Ex vivo, atorvastatin suppressed the proliferation of splenic B lymphocytes. CONCLUSION: Oral atorvastatin monotherapy had no therapeu …
In vivo, the effects of atorvastatin on the survival rate, renal function and spleen index in MRL/lpr mice were examined. ...Ex vivo, …
12,628 results
You have reached the last available page of results. Please see the User Guide for more information.